Dr. Joanne Maki Bando, MD

Dr. Bando practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Bando's NPI, 1609083773, was assigned on May 17, 2007. Dr. Bando graduated from UC Davis School of Medicine in 2002. Dr. Bando holds California license A86395.

Dr. Bando's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Bando's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Bando is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Bando to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bando practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bando's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bando is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Bando is licensed in California.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), hypersomnia, pleural effusion, pneumonia, pulmonary fibrosis and sleep apnea among the conditions Dr. Bando treats.

CMS data shows 1,250 Medicare services from Dr. Bando across 14 procedure codes in 2024, for 380 Medicare patients. Medicare paid $140,719 for them.

CMS counts 380 Medicare patients who saw Dr. Bando in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bando's median patient age at 69, with 57% women.

In 2024, Dr. Bando wrote 943 Medicare Part D claims for 165 patients. 55% of them were for generic drugs. CMS names the drug for 822 of them, across 21 drugs with 11 or more claims each, at $214,619 in total drug cost. In 2023, CMS named 887 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bando for performance year 2024, reported as part of a group. Dr. Bando accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bando as offering telehealth.

Dmand AI links 5 papers to Dr. Bando in 2014. Dr. Bando's most frequent co-authors are Jeffrey Grande Albores, MD, Ravi Shankar Aysola, MD and Igor Barjaktarevic, MD, MS.

CMS Open Payments shows 5 general payments to Dr. Bando from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $132.

Dr. Bando graduated from UC Davis School of Medicine in 2002.

Dr. Bando is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.